
Allways is building a direct cross-asset transaction layer so users can exchange native assets in one flow, but the public product today is still an early developer-facing beta.
NIOME lets pharmaceutical and research teams work with privacy-safe synthetic human genome datasets for drug-response and precision-medicine research without exposing real patient DNA.
Yanez lets compliance teams test whether identity checks, sanctions screening, and fraud controls hold up against realistic synthetic identities and related attack scenarios.
Enigma is being built as a prize-based coding challenge platform where researchers and developers try to solve or harden difficult technical problems, but the public portal was still marked "Coming Soon" during research.
AdTAO is a Google Ads management app for agencies and freelancers that helps identify likely account problems, estimate the likely impact of proposed fixes, and review suggested changes before applying them.